BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7449319)

  • 1. [Trithiozine versus propantheline in the therapy of gastric ulcer: double-blind clinical studies].
    Marini U; Visconti GP; Spotti D; Geniram A
    Clin Ter; 1980 Feb; 92(4):399-408. PubMed ID: 7449319
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical effects of trithiozine, a newer gastric anti-secretory agent.
    Pellegrini R
    J Int Med Res; 1979; 7(5):452-8. PubMed ID: 387498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment of trithiozine for duodenal ulcer.
    Rybicka J; Gibiński K
    Acta Med Pol; 1980; 21(2):159-64. PubMed ID: 7211464
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-over clinical comparison between anti-secretory activity of propantheline bromide and trithiozine (I.S.F. 2001).
    Corinaldesi R; Luchetta L; Ricci P; Guidoboni R; Casadio R; Fabbri R; Barbara L
    Panminerva Med; 1977; 19(5):339-44. PubMed ID: 341044
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind double-dummy crossover comparison of the effect of a single dose of cimetidine and trithiozine on gastric secretion.
    Procacciante F; Benvenuti C; Citone G; Montesani C; Ribotta G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):62-6. PubMed ID: 7372377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trithiozine and peptic ulcer. Double-blind clinical study].
    Catalano F; Brogna A; Blasi A
    Minerva Dietol Gastroenterol; 1978; 24(3):197-201. PubMed ID: 368681
    [No Abstract]   [Full Text] [Related]  

  • 7. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
    Lazzaroni M; Perego M; Bargiggia S; Maconi G; Fiocca R; Solcia E; Franceschi M; Cesana B; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):220-7. PubMed ID: 9646213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibiting action of trithiozine (ISF 2001) and of propantheline on gastric secretion in humans. Double-blind cross-over studies].
    Bianchi Porro G; Petrillo M; Ferrara A; Abbondati G
    Minerva Gastroenterol; 1976; 22(2):149-52. PubMed ID: 787828
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
    Pal'tsev AI; Maslennikova TA
    Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of gastroduodenitis. Controlled evaluation of trithiozine].
    Forni E; Pinchetti R; Tinozzi S
    Minerva Dietol Gastroenterol; 1978; 24(3):237-46. PubMed ID: 368682
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of bleeding peptic ulcers with omeprazole.
    Munkel L; French L
    J Fam Pract; 1997 Jul; 45(1):20-1. PubMed ID: 9228906
    [No Abstract]   [Full Text] [Related]  

  • 14. [The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
    Riva D; Manieri L; Mariano P
    Arch Sci Med (Torino); 1980; 137(3):461-6. PubMed ID: 6112973
    [No Abstract]   [Full Text] [Related]  

  • 15. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental testing of a new gastrotherapeutic agent].
    Reikowski H
    Fortschr Med; 1976 Jan; 94(3):151-6. PubMed ID: 3461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some problems concerning the evaluation of modern contra-ulcerous drugs. Comparison of four medicaments suppressing gastric acidity (author's transl)].
    Gibinski K
    Cesk Gastroenterol Vyz; 1981 May; 35(3):118-22. PubMed ID: 6269763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of anti-ulcer agents judged from background factors of stomach ulcer].
    Fukuchi S; Yoshida Y; Yamada N; Hayakawa K; Hashimoto M; Ueda O; Ito K; Hoshihara Y
    Nihon Rinsho; 1984 Jan; 42(1):144-9. PubMed ID: 6716666
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of prostacyclin in patients with stomach ulcer in a double-blind clinical trial].
    Dembińska-Kieć A; Kostka-Trabka E; Kosiniak-Kamysz A; Grodzińska L; Bieroń K; Dabrowski L; Kedzior A; Basista M; Gaertner H
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1650-4. PubMed ID: 3295818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.